Charles LeMoyne Hospital
2 clinical trials · Sponsor
◉ Watch Charles LeMoyne Hospital
| Record | Firm | Date |
|---|---|---|
| IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life (NCT07478315) | Charles LeMoyne Hospital | 2026-03-15 |
| Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months. (NCT06855589) | Charles LeMoyne Hospital | 2025-03-01 |
Track Charles LeMoyne Hospital automatically
Every clearance here is in the API, with alerts when new ones post.